Skip to main content
Clinical Trials/NCT03363243
NCT03363243
Completed
Not Applicable

Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain

University of Colorado, Denver1 site in 1 country52 target enrollmentMarch 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid-use Disorder
Sponsor
University of Colorado, Denver
Enrollment
52
Locations
1
Primary Endpoint
Changes in Daily Functioning - Pain
Status
Completed
Last Updated
last year

Overview

Brief Summary

The public health relevance of this proposed project is substantial given the current opioid abuse epidemic as identified by the Centers for Disease Control (CDC). This study finalizes and tests a new psychotherapy treatment that is designed to treat chronic pain and opioid addiction at the same time in a format that could be easily used in a community addiction treatment setting. Final products of the study will yield an integrated STOP (Self-regulation/Cognitive-behavioral therapy (CBT) Therapy for Opioid addiction and Pain) manual guided protocol, patient workbook, and therapist training protocol.

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
June 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-65 years old;
  • Willing to adhere to study protocol including treatment sessions and assessments;
  • Individuals have a history of co-morbid opioid use disorder and chronic pain;
  • Cognitively able to participate and give informed consent.

Exclusion Criteria

  • Acute or unstable psychotic disorder;
  • Psychiatric hospitalization or suicide attempt in the past 3 months
  • Patient has been diagnosed with an unstable cardiovascular condition including: myocardial infarction, arrhythmia, or poorly controlled hypertension in the past 3 months
  • Lack of verbal and written English fluency
  • Over the age of 65 since evidence suggests pain perception alters with age

Outcomes

Primary Outcomes

Changes in Daily Functioning - Pain

Time Frame: Baseline (week 1) to post-treatment assessment time-point (week 14) and to a 1-month post-treatment follow-up assessment for each participant (approximately 4-5 month total time frame per participant)

Multi-dimensional pain inventory - 60 items (participant ratings 0 to 6 on various measures, from none to extreme or from never to very often, related to their pain and functioning); subscales (ratings in each subscale are averaged to form subscale scores): Interference, Support, Pain Severity, Life-Control, Affective Distress, Negative Responses, Solicitous Responses, Distracting Responses, Household Chores, Outdoor Work, Activities Away from Home, Social Activities, General Activity

Secondary Outcomes

  • Changes in Substance Use(Baseline (week 1), then assessed weekly over the course of the therapy treatment (approximately 4-5 months for each participant))

Study Sites (1)

Loading locations...

Similar Trials